loading

Eton Pharmaceuticals Inc Azioni (ETON) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
9.52%
18.93
17.28 11.65 10.32 9.074
Cost Of Revenue
5.62%
7.004
7.421 5.171 4.022 3.448
Gross Profit
20.92%
11.92
9.861 6.476 6.302 5.626
Operating Expenses
29.70%
13.40
10.33 5.847 5.793 8.561
Interest Income/Expense
3.01%
1.198
1.163 - 0.211 0.222
Benefits Costs and Expenses
14.20%
21.45
18.78 12.16 9.823 12.06
Costs And Expenses
14.20%
21.45
18.78 12.16 9.823 12.06
Depreciation and Amortization
0.79%
1.005
1.013 0.355 0.278 0.261
Operating Income/Loss
213.83%
-1.475
-0.47 0.629 0.509 -2.935
Income/Loss From Continuing Operations Before Tax
68.16%
-2.519
-1.498 -0.511 0.501 -2.987
Income Tax Expense/Benefit
10.81%
0.066
0.074 0.087 -0.126 0.054
Income/Loss From Continuing Operations After Tax
64.44%
-2.585
-1.572 -0.598 0.627 -3.041
Net Income/Loss
64.44%
-2.585
-1.572 -0.598 0.627 -3.041
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.03%
26.89
26.89 25.87 0.0259 0.0258
Basic Earnings Per Share
66.67%
-0.10
-0.06 -0.03 0.02 -0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$28.31
price down icon 6.41%
$18.71
price up icon 1.64%
drug_manufacturers_specialty_generic RDY
$14.22
price down icon 0.80%
$10.43
price down icon 0.75%
$143.77
price down icon 0.24%
$390.62
price down icon 2.47%
Capitalizzazione:     |  Volume (24 ore):